Eli Lilly's Retatrutide Draws Attention Ahead of Earnings Report | Retatrutide News

Eli Lilly's earnings report on October 29 will be overshadowed by interest in Retatrutide, a GLP-1 agonist. The drug's potential impact on weight manage...
Market News · October 15, 2026